Microbial Fermentation Technology Market Size, Share & Trends Report

Microbial Fermentation Technology Market Size, Share & Trends Analysis Report By Application (Antibiotics, Vaccines), By End-user (Biopharmaceutical Companies), By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68039-983-0
Number of Pages: 120
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Microbial Fermentation Technology Application Outlook (Revenue, USD Million, 2018 - 2030)
- Antibiotics
- Probiotics Supplements
- Monoclonal Antibodies
- Recombinant Proteins
- Biosimilars
- Vaccines
- Enzymes
- Small Molecules
- Others
Microbial Fermentation Technology End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Bio-Pharmaceutical Companies
- Contract Research Organizations (CROs)
- CMOs & CDMOs
- Academic & Research Institutes
Microbial Fermentation Technology Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Microbial Fermentation Technology Market, By Application
    - Antibiotics
    - Probiotics Supplements
    - Monoclonal Antibodies
    - Recombinant Proteins
    - Biosimilars
    - Vaccines
    - Enzymes
    - Small Molecules
    - Others
  - North America Microbial Fermentation Technology Market, By End Use
    - Bio-Pharmaceutical Companies
    - Contract Research Organizations (CROs)
    - CMOs & CDMOs
    - Academic Research Institutes
  - U.S.
    - U.S. Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - U.S. Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - Canada
    - Canada Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Canada Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
- Europe
  - Europe Microbial Fermentation Technology Market, By Application
    - Antibiotics
    - Probiotics Supplements
    - Monoclonal Antibodies
    - Recombinant Proteins
    - Biosimilars
    - Vaccines
    - Enzymes
    - Small Molecules
    - Others
  - Europe Microbial Fermentation Technology Market, By End Use
    - Bio-Pharmaceutical Companies
    - Contract Research Organizations (CROs)
    - CMOs & CDMOs
    - Academic Research Institutes
  - Germany
    - Germany Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Germany Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - UK
    - UK Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - UK Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - France
    - France Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - France Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - Italy
    - Italy Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Italy Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - Spain
    - Spain Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Spain Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - Norway
    - Norway Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Norway Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - Denmark
    - Denmark Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Denmark Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - Sweden
    - Sweden Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Sweden Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
- Asia Pacific
  - Asia Pacific Microbial Fermentation Technology Market, By Application
    - Antibiotics
    - Probiotics Supplements
    - Monoclonal Antibodies
    - Recombinant Proteins
    - Biosimilars
    - Vaccines
    - Enzymes
    - Small Molecules
    - Others
  - Asia Pacific Microbial Fermentation Technology Market, By End Use
    - Bio-Pharmaceutical Companies
    - Contract Research Organizations (CROs)
    - CMOs & CDMOs
    - Academic Research Institutes
  - China
    - China Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - China Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - Japan
    - Japan Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Japan Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - India
    - India Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - India Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - South Korea
    - South Korea Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - South Korea Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - Australia
    - Australia Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Australia Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - Thailand
    - Thailand Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Thailand Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
- Latin America
  - Latin America Microbial Fermentation Technology Market, By Application
    - Antibiotics
    - Probiotics Supplements
    - Monoclonal Antibodies
    - Recombinant Proteins
    - Biosimilars
    - Vaccines
    - Enzymes
    - Small Molecules
    - Others
  - Latin America Microbial Fermentation Technology Market, By End Use
    - Bio-Pharmaceutical Companies
    - Contract Research Organizations (CROs)
    - CMOs & CDMOs
    - Academic Research Institutes
  - Brazil
    - Brazil Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Brazil Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - Mexico
    - Mexico Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Mexico Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - Argentina
    - Argentina Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Argentina Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
- MEA
  - MEA Microbial Fermentation Technology Market, By Application
    - Antibiotics
    - Probiotics Supplements
    - Monoclonal Antibodies
    - Recombinant Proteins
    - Biosimilars
    - Vaccines
    - Enzymes
    - Small Molecules
    - Others
  - MEA Microbial Fermentation Technology Market, By End Use
    - Bio-Pharmaceutical Companies
    - Contract Research Organizations (CROs)
    - CMOs & CDMOs
    - Academic Research Institutes
  - South Africa
    - South Africa Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - South Africa Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - Saudi Arabia
    - Saudi Arabia Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Saudi Arabia Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - UAE
    - UAE Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - UAE Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes
  - Kuwait
    - Kuwait Microbial Fermentation Technology Market, By Application
      - Antibiotics
      - Probiotics Supplements
      - Monoclonal Antibodies
      - Recombinant Proteins
      - Biosimilars
      - Vaccines
      - Enzymes
      - Small Molecules
      - Others
    - Kuwait Microbial Fermentation Technology Market, By End Use
      - Bio-Pharmaceutical Companies
      - Contract Research Organizations (CROs)
      - CMOs & CDMOs
      - Academic Research Institutes

Microbial Fermentation Technology Market Dynamics

Drivers: Increasing Usage Of Fermentation-Derived Products In Various Industries

Microbial fermentation-derived products have applications in various industries, such as biopharmaceuticals, probiotics, recombinant proteins & peptides, and others. Technology applications are further expected to expand due to the increasing adoption of smaller, complex next-generation molecules, such as antibody fragments and bioconjugates, among other novel molecules. In addition, microbial fermentation is preferred for producing smaller biologics, including cytokines, growth factors, nucleic acids, plasmid DNA, & nonglycosylated antibody fragments, due to the shorter processing times and lower media costs compared to animal cell cultures. Furthermore, the ability of microbes to be genetically engineered to produce large quantities of biological products at high concentrations can boost their use in the large-scale manufacture of vaccines and therapeutics.

The increasing use of microbial fermentation technology in various industries is driven by the advantages offered by the technology over mammalian cell cultures. For instance, microbial cultures can provide higher yields & quality, reduced batch-to-batch variations, better scalability, and lower costs for production of antibodies & industrially relevant enzymes.

Rising : R&D Activities In Fermentation Technology

Microbial fermentation technology has a broad range of applications in the biopharmaceutical and biotechnology domains. As a result, the industry is projected to witness significant growth in the coming years due to rising government funding and private investments for R&D activities in biotechnology. For instance, in 2019, over USD 14.92 billion was invested in various life science companies globally, of which approximately 64.6% was taken up by the biotechnology sector. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the biopharmaceutical industry invested over USD 102 billion in R&D activities in 2018. According to the 2019 PhRMA member annual survey, over USD 79.6 billion was invested in biopharmaceutical R&D by member companies. With rapid growth in biopharmaceuticals in recent years, such investments are expected to drive the adoption of advanced microbial fermentation systems to increase the efficiency and scale of manufacturing biologics.

Moreover, companies operating in microbial fermentation technology are further fueling the market with the help of service offerings that support R&D activities. For instance, companies, such as Microbiosci (Creative Biogene), offer strain development and fermentation services to boost the development and manufacture of microbial products used in industrial applications. Similarly, ongoing developments in genomics, metabolomics, and proteomics reveal new prospects for the growth of R&D activities to investigate microbial fermentation in therapeutics.

Restraints: Technological Challenges Associated With Microbial Fermentation

Microbial fermentation at an industrial scale depends on several parameters that may lead to a failure in production. For instance, microorganisms may be intrinsically limited in their ability to produce desired products from raw materials that are economically viable. Moreover, the availability of raw materials with desired quality and purity represents a significant challenge for the scale-up of successful pilot projects. In addition, fermentation may result in toxic byproducts that can lead to inhibition of the fermentation process, or the process may be negatively affected due to the presence of competing microorganisms present in the fermenters. Other challenges, such as inefficient metabolic flow and high costs of downstream processing methods caused by the physicochemical characteristics of the substrate or the product, may lead to additional complexities in the microbial fermentation process. These factors indicate several technological factors that may limit the adoption of microbial fermentation technology and hinder market growth over the forecast period.

What Does This Report Include?

This section will provide insights into the contents included in this microbial fermentation technology market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Microbial fermentation technology market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Microbial fermentation technology market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.